Sublingual Apomorphine

Patent No. EP2442650 (titled "Sublingual Apomorphine") was filed by Adagio Pharmaceuticals on Jun 11, 2010. The application was issued on May 14, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
LTS LOHMANN THERAPIE SYSTEMEMay 27, 2016MEISSNER BOLTE PARTNERSCHAFT MBB
GENERICS UKMay 26, 2016FRKELLY

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2442650

ADAGIO PHARMACEUTICALS
Application Number
EP10786915A
Filing Date
Jun 11, 2010
Status
Patent Maintained As Amended
Apr 11, 2025
Publication Date
May 14, 2025